NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Forecast, Price & News

$1.04

+0.08 (+8.33%)

(As of 06/8/2023 ET)

Compare

Today's Range: $0.96
▼
$1.10
50-Day Range: $0.84
▼
$1.14
52-Week Range: $0.80
▼
$1.50

Volume: 294,953 shs
Average Volume: 32,362 shs
Market Capitalization: $39.63 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Trinity Biotech MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.08% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.43
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.22) to $0.14 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Medical Sector

911th out of 986 stocks

Diagnostic Substances Industry

13th out of 15 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Trinity Biotech.

5.0

Short Interest

Percentage of Shares Shorted
0.08% of the outstanding shares of Trinity Biotech have been sold short.
Short Interest Ratio / Days to Cover
Trinity Biotech has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Trinity Biotech has recently decreased by 18.33%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Trinity Biotech does not currently pay a dividend.
Dividend Growth
Trinity Biotech does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TRIB.

2.5

News and Social Media Coverage

News Sentiment
Trinity Biotech has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 1 article on an average week.
MarketBeat Follows
1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Trinity Biotech insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.20% of the stock of Trinity Biotech is held by insiders.
Percentage Held by Institutions
Only 18.41% of the stock of Trinity Biotech is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Trinity Biotech are expected to grow in the coming year, from ($0.22) to $0.14 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Trinity Biotech is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Trinity Biotech is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Trinity Biotech (NASDAQ:TRIB) Stock

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

June 3, 2023 | finance.yahoo.com

Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

June 3, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com

June 9, 2023 | UNKNOWN (Ad)

Lithium Has Boomed And This American Stock Is Ready..

Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!

June 2, 2023 | msn.com

Trinity Biotech to add up to 40 news jobs at Wicklow headquarters

May 29, 2023 | americanbankingnews.com

Head-To-Head Comparison: Lucira Health (NASDAQ:LHDXQ) and Trinity Biotech (NASDAQ:TRIB)

May 26, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com

May 18, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Receives New Coverage from Analysts at StockNews.com

May 9, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com

June 9, 2023 | UNKNOWN (Ad)

Lithium Has Boomed And This American Stock Is Ready..

Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!

May 5, 2023 | finance.yahoo.com

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

May 1, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.com

April 29, 2023 | americanbankingnews.com

Trinity Biotech plc (NASDAQ:TRIB) Sees Significant Growth in Short Interest

April 28, 2023 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

April 27, 2023 | finance.yahoo.com

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

April 24, 2023 | finance.yahoo.com

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

April 24, 2023 | americanbankingnews.com

Cardio Diagnostics (NASDAQ:CDIO) versus Trinity Biotech (NASDAQ:TRIB) Head-To-Head Review

April 23, 2023 | finance.yahoo.com

This Trinity Biotech plc (NASDAQ:TRIB) Analyst Is Way More Bearish Than They Used To Be

April 20, 2023 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

April 20, 2023 | benzinga.com

Why Trinity Biotech Stock Is Moving Up Today

April 16, 2023 | americanbankingnews.com

Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com

April 9, 2023 | msn.com

Pennsylvania Biotech Center In Doylestown Launches Podcast

April 9, 2023 | msn.com

Trinity Biotech writes down value of two Covid tests to zero, with demand ‘highly uncertain’

March 27, 2023 | insidermonkey.com

Trinity Biotech plc (NASDAQ:TRIB) Q4 2022 Earnings Call Transcript

March 25, 2023 | finance.yahoo.com

What Is Trinity Biotech plc's (NASDAQ:TRIB) Share Price Doing?

March 23, 2023 | finance.yahoo.com

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

March 22, 2023 | marketwatch.com

Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing Algorithm

March 22, 2023 | finance.yahoo.com

Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm

See More Headlines

TRIB Price History

30 days | 90 days | 365 days | Advanced Chart

TRIB Company Calendar

Last Earnings: 3/23/2023
Today: 6/08/2023
Next Earnings (Estimated): 6/29/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:TRIB
CUSIP: N/A
CIK: 888721
Web: www.trinitybiotech.com
Phone: (531) 276-9800
Fax: 353-1276-9888
Employees: 543
Year Founded: 1992

Profitability

EPS (Most Recent Fiscal Year): ($1.29)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-41,010,000.00
Net Margins: -54.84%
Pretax Margin: -55.09%
Return on Equity: -724.07%
Return on Assets: -25.12%

Debt

Debt-to-Equity Ratio: 8.70
Current Ratio: 2.69
Quick Ratio: 1.39

Sales & Book Value

Annual Sales: $74.78 million
Price / Sales: 0.53
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.06) per share
Price / Book: -17.33

Miscellaneous

Outstanding Shares: 38,110,000
Free Float: 34,983,000
Market Cap: $39.63 million
Optionable: Optionable
Beta: 1.41

Social Links

Key Executives

Aris Kekedjian
Chairman & Chief Executive Officer

John Gillard
CFO, Secretary & Executive Director

Eibhlin Kelly
Chief Information Officer

Terence Dunne
Director-Business Development

Fernando Devia
Executive Vice President-Sales

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

TRIB Stock - Frequently Asked Questions

How have TRIB shares performed in 2023?: Trinity Biotech's stock was trading at $0.99 at the start of the year. Since then, TRIB stock has increased by 5.1% and is now trading at $1.04.
View the best growth stocks for 2023 here.
Are investors shorting Trinity Biotech?: Trinity Biotech saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 29,400 shares, a decrease of 18.3% from the April 30th total of 36,000 shares. Based on an average daily trading volume, of 36,200 shares, the days-to-cover ratio is currently 0.8 days.
View Trinity Biotech's Short Interest.
When is Trinity Biotech's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our TRIB earnings forecast.
How were Trinity Biotech's earnings last quarter?: Trinity Biotech plc (NASDAQ:TRIB) announced its earnings results on Thursday, March, 23rd. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.12. The company had revenue of $18.04 million for the quarter, compared to the consensus estimate of $18 million. Trinity Biotech had a negative net margin of 54.84% and a negative trailing twelve-month return on equity of 724.07%.
What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?: 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Trinity Biotech own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

What is Trinity Biotech's stock symbol?: Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."
Who are Trinity Biotech's major shareholders?: Trinity Biotech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Hunter Associates Investment Management LLC (4.66%), Renaissance Technologies LLC (3.61%), Aristides Capital LLC (0.43%), Envestnet Asset Management Inc. (0.14%) and Group One Trading L.P. (0.00%).
How do I buy shares of Trinity Biotech?: Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Trinity Biotech's stock price today?: One share of TRIB stock can currently be purchased for approximately $1.04.
How much money does Trinity Biotech make?: Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $39.63 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis.
How many employees does Trinity Biotech have?: The company employs 543 workers across the globe.
How can I contact Trinity Biotech?: Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.

This page (NASDAQ:TRIB) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial